In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent-Reference-Cited by-同舟云学术

In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

Published:2004-11-23 Issue:6 Volume:52 Page:1263-1271
ISSN:0740-3194
Container-title:Magnetic Resonance in Medicine
language:en
Short-container-title:Magn. Reson. Med.

Author:

Jack Clifford R.,Garwood Michael,Wengenack Thomas M.,Borowski Bret,Curran Geoffrey L.,Lin Joseph,Adriany Gregor,Gröhn Olli H. J.,Grimm Roger,Poduslo Joseph F.

Funder

National Institutes of Health

W. M. Keck Foundation

MIND Institute

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Reference31 articles.

1. Prevalence of Alzheimer's disease in a community population of older persons;Evans;JAMA,1989

2. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease;McKhann;Neurology,1984

3. Biomarkers of Alzheimer disease;Growdon;Arch Neurol,1999

4. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics;Hardy;Science,2002

5. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice;Hsiao;Science,1996

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct regional vulnerability to Aβ and iron accumulation in post mortem AD brains;Alzheimer's & Dementia;2024-08-23

2. A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics;Pharmaceutics;2023-09-13

3. Multimodal comparisons of QSM and PET in neurodegeneration and aging;NeuroImage;2023-06

4. Correlation between Phase-difference-enhanced MR Imaging and Amyloid Positron Emission Tomography: A Study on Alzheimer’s Disease Patients and Normal Controls;Magnetic Resonance in Medical Sciences;2023

5. Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations;Frontiers in Neuroscience;2022-08-05